Sydney Pia Hernandez, FNP-C
Family · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Sydney Pia Hernandez’s office at (888) 731-8994 to ask if they take your plan before you enroll.
Medicaid work
$7,895 in 2023
Medicaid paid $7,895 for 103 billed services this clinician did in 2023, up to 28 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 91 | $7,876 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 12 | $19 |
| 2023 | 103 | 2 | 28 | $7,895 |
| 2022 | 54 | 2 | 14 | $3,643 |
| 2021 | 44 | 2 | 16 | $2,902 |
See the largest Medicaid services in earlier years
2022
| Return visit (30+ min) | 28 | $2,108 |
| Short return visit (20+ min) | 26 | $1,535 |
2021
| Return visit (30+ min) | 30 | $2,127 |
| Short return visit (20+ min) | 14 | $775 |
Drugs they prescribed that Part D paid
$951
Pharmacies billed $951 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 49) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
40 generic and fewer than 11 brand-name prescriptions · $951 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 49 | 16 | 0% (0) | None | $951 |
| 2023 | 598 | 98 | None | 13% | $41,509 |
| 2022 | 892 | 97 | None | 16% | $47,774 |
| 2021 | 626 | 77 | None | None | $36,159 |
| 2020 | 48 | 23 | 0% (0) | None | $1,804 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Levothyroxine | 35 | $869 | $25 |
| Metformin | 28 | $555 | $20 |
| Atorvastatin | 30 | $533 | $18 |
| Albuterol Sulfate Hfa | 13 | $507 | $39 |
| Metoprolol | 22 | $439 | $20 |
| Duloxetine | 16 | $419 | $26 |
| Losartan | 26 | $349 | $13 |
| Escitalopram | 12 | $246 | $21 |
| Risperidone | 24 | $233 | $10 |
| Omeprazole | 19 | $174 | $9 |
| Amlodipine Besylate | 28 | $121 | $4 |
| Lisinopril | 25 | $98 | $4 |
| Simvastatin | 16 | $68 | $4 |
2022: 25 drugs
| Advair Hfa | 12 | $4,695 | $391 |
| Livalo | 11 | $3,457 | $314 |
| Levothyroxine | 68 | $1,684 | $25 |
| Estradiol | 24 | $1,159 | $48 |
| Synthroid | 13 | $931 | $72 |
| Omeprazole | 46 | $597 | $13 |
| Atorvastatin | 37 | $592 | $16 |
| Losartan | 48 | $584 | $12 |
| Metoprolol | 20 | $562 | $28 |
| Albuterol Sulfate Hfa | 14 | $489 | $35 |
| Escitalopram | 26 | $489 | $19 |
| Clopidogrel | 15 | $284 | $19 |
| Montelukast | 13 | $242 | $19 |
| Risperidone | 19 | $235 | $12 |
| Losartan-Hydrochlorothiazide | 16 | $231 | $14 |
| Hyoscyamine Sulfate | 27 | $176 | $7 |
| Metformin | 40 | $165 | $4 |
| Amlodipine Besylate | 39 | $162 | $4 |
| Lisinopril | 26 | $113 | $4 |
| Pantoprazole | 11 | $65 | $6 |
| Dicyclomine | 14 | $52 | $4 |
| Simvastatin | 15 | $46 | $3 |
| Hydrochlorothiazide | 15 | $40 | $3 |
| Lisinopril-Hydrochlorothiazide | 12 | $38 | $3 |
| Ondansetron | 12 | $0 | $0 |
2021: 13 drugs
| Levothyroxine | 51 | $1,298 | $25 |
| Memantine | 12 | $627 | $52 |
| Losartan | 26 | $446 | $17 |
| Omeprazole | 20 | $384 | $19 |
| Estradiol | 14 | $365 | $26 |
| Escitalopram | 26 | $358 | $14 |
| Atorvastatin | 19 | $316 | $17 |
| Montelukast | 17 | $309 | $18 |
| Metformin Hcl Er | 11 | $105 | $10 |
| Metformin | 32 | $93 | $3 |
| Lisinopril | 18 | $74 | $4 |
| Simvastatin | 13 | $67 | $5 |
| Amlodipine Besylate | 23 | $58 | $3 |
Money from drug and device companies
$14 in 2024
| 2024 | 1 | 1 | None | $14 |
| 2023 | 4 | 6 | None | $97 |
| 2022 | 4 | 7 | None | $109 |
| 2021 | 4 | 10 | None | $150 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | None | $14 | 1 payment
|
See the published payment
| Boston Scientific | Meals · 2024-02-23 | None | $14 |
See earlier years (2023, 2022, 2021)
2023: $97
| Abbvie | Vraylar | $56 | 3 payments
|
| Lilly USA | Emgality | $17 | 1 payment
|
| Novo Nordisk | Ozempic | $14 | 1 payment
|
| Mayne Pharma Commercial | None | $9 | 1 payment
|
2022: $109
| Lilly USA | Jardiance | $55 | 4 payments
|
| Abbvie | Ubrelvy | $23 | 1 payment
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $16 | 1 payment
|
| Novo Nordisk | Rybelsus | $15 | 1 payment
|
2021: $150
| Lilly USA | Trulicity | $64 | 5 payments
|
| Pfizer | Cologuard Dna Capture Reagents | $54 | 3 payments
|
| IBSA Pharma | Tirosint | $17 | 1 payment
|
| Eisai | Dayvigo | $14 | 1 payment
|
Professional record
- NPI
- 1144869348
- Licence
- ID 62037
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 195 Page Mill Rd Ste 103, Palo Alto, CA, 94306
- NPI first listed
- 2020-01-06
- NPI last updated
- 2025-02-03
- NPI record certified
- 2025-02-03
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 950 W Bannock St Ste 1100, Boise, ID, 83702 · 112 Maverick Ct, Granbury, TX, 76049